Industry
Latest
- Industry
720 Rural Hospitals at Risk of Closure as Surgical Access Gaps Widen
A Center for Healthcare Quality and Payment Reform report finds that roughly one-third of rural hospitals — 720 facilities — face closure risk, raising questions about surgical access in underserved areas. As rural hospitals retreat from operating room services, the analysis highlights growing surgical care deserts. The report does not specify a timeline for closures but underscores ongoing financial instability in rural provider markets. For Medicaid managed care organizations with rural network obligations, this trend signals potential network adequacy challenges and increased need for alternative surgical access strategies.
- Industry
Elevance Health Plans Further Medicaid Portfolio Exit Amid High Costs
Elevance Health, the nation's second-largest health insurer, announced plans to reduce its Medicaid managed care footprint over the next year as medical costs remain elevated. The exit comes as states prepare to implement Medicaid work requirements. Elevance operates Medicaid plans in multiple states under its Anthem and Wellpoint brands. The decision reflects ongoing profitability challenges in Medicaid managed care following the end of pandemic-era continuous enrollment provisions.
- Industry
FTC Settles with CVS Caremark Over Insulin Price Manipulation Claims
The Federal Trade Commission has settled a lawsuit against CVS Caremark over allegations the company artificially inflated insulin prices and restricted access to diabetes treatment. The settlement resolves FTC charges related to the pharmacy benefit manager's pricing practices for insulin products. The action follows broader federal scrutiny of PBM practices affecting drug pricing and access. Terms of the settlement were not disclosed in the initial report.
- Industry
CVS Caremark Settles FTC Insulin Suit, Must End Rebate-Driven Formulary Preferences
CVS Caremark reached a settlement with the Federal Trade Commission over insulin pricing practices. The terms mirror the FTC's earlier settlement with Express Scripts and prohibit the pharmacy benefit manager from favoring higher-cost drug versions on standard formularies based on rebate arrangements. The settlement takes effect immediately upon court approval. For Medicaid managed care plans that contract with CVS Caremark or operate integrated PBM arrangements, this settlement signals continued federal scrutiny of rebate-driven formulary design and may preview future enforcement against similar practices affecting Medicaid populations.
- Industry
HHS Secretary Kennedy Advances Initiative to Reduce SSRI Antidepressant Use
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is moving forward with an initiative aimed at helping Americans discontinue selective serotonin reuptake inhibitor (SSRI) antidepressants. The effort represents a significant policy shift at the federal level regarding mental health treatment approaches. The initiative's specific implementation mechanisms, timeline, and scope remain unclear from available reporting. For Medicaid managed care organizations, any federal guidance or directives affecting prescription psychiatric medications could have major implications for behavioral health benefit design, formulary management, prior authorization protocols, and member continuity of care.
- Industry
HCA Reports Lower Profits as Uninsured Patient Volume Rises After ACA Subsidy Expiration
Hospital chain HCA Healthcare reported declining profits attributed to increased uninsured patient volume following the expiration of enhanced Affordable Care Act subsidies. The company cited rising uncompensated care costs as patients lost marketplace coverage. This represents an early signal of coverage losses affecting provider revenues after the federal government allowed pandemic-era ACA premium subsidies to lapse. The trend may accelerate Medicaid enrollment as individuals lose private coverage and income-qualify for state programs.
- Industry
AIDS Activists Obtain Biden-Gilead HIV Prevention Patent Settlement R&D Agreement
AIDS activists have obtained a research and development agreement that formed the basis of a settlement between the Biden administration and Gilead Sciences concerning patents for HIV prevention drugs. The activists are criticizing the terms of the settlement deal. The agreement relates to pre-exposure prophylaxis (PrEP) medications used to prevent HIV transmission. This development follows years of dispute over whether the federal government held patent rights to Gilead's HIV prevention drugs and the terms under which those drugs should be made available.
- Industry
House Passes Bipartisan Tax Credit Extension Bill
The U.S. House of Representatives approved a bipartisan bill extending tax credits on January 8, 2026. The Association for Community Affiliated Plans (ACAP) CEO Margaret A. Murray issued a statement following the vote. The bill now moves to the Senate for consideration. Specific details on which tax credits are extended and the duration of the extension were not provided in the available excerpt.
- Industry
Home Health Care News Profiles Six Home Care Companies for 2026
Home Health Care News published a profile of six home care companies navigating operational challenges in 2026. The article cites Medicaid reimbursement pressures, proposed 80-hour work requirements, fraud enforcement, technology adoption, and mergers and acquisitions as key factors shaping the sector. The publication does not report specific policy changes or enforcement actions, but rather frames the operating environment for home care providers. No effective dates or comment periods are provided because this is an industry profile rather than a policy document.
- Industry
Sturgis Hospital Closes After 101 Years as 720 U.S. Hospitals Face Closure Risk
Sturgis Hospital in Michigan closed June 19, 2026, after 101 years of operation, following a 13% volume decrease over two years. An estimated 720 hospitals nationwide are at risk of closure. The closures disproportionately affect rural facilities facing declining patient volumes and financial pressures. For Medicaid managed care organizations, rural hospital closures threaten network adequacy, emergency access, and continuity of care for beneficiaries in underserved areas.
- Industry · IA
CommonSpirit Closes Labor and Delivery Services at Iowa Hospital
CHI Health Mercy Council Bluffs will end labor and delivery and Level 2 NICU services on August 31, 2026. CommonSpirit Health will consolidate these services at its Omaha birth centers, located approximately 15 minutes away, which currently deliver over 4,460 babies annually. Patients will transition to the Omaha facilities for obstetric care.
- Industry
Dementia Costs Projected at $818 Billion in 2026, Threatening Home Health Workforce
Dementia and Alzheimer's disease are projected to cost the United States $818 billion in 2026, with families and individuals bearing more than 80% of the economic burden according to a study in Alzheimer's & Dementia. Flournoy Health Systems CEO warns this growing cost pressure could further strain the home health workforce. The projections come as managed care organizations face increasing demand for long-term services and supports, particularly home and community-based services for members with cognitive impairment. The workforce impact threatens network adequacy for LTSS benefits.
- Industry
ACA Marketplace Insurers Propose 14% Premium Increase for 2027
Insurers participating in ACA Marketplaces are proposing a median premium increase of 14% for 2027, based on preliminary rate filings analyzed in 16 states and DC. This follows steep increases in 2026, bringing total premium growth to over one-third between 2025 and 2027. The analysis reflects preliminary filings subject to final regulatory review. Final rates will be determined later in 2026 ahead of the 2027 plan year.
- Industry
Menopause Complications Drive Utilization in Chronically Ill Populations
Menopause destabilizes chronic disease management in high-risk populations, leading to increased healthcare utilization and costs that are often not recognized in care planning. For patients already managing chronic conditions, menopause-related changes can complicate treatment adherence and clinical stability. The effects manifest over time in higher utilization rates and worse outcomes. Medicaid managed care organizations serving populations with high chronic disease burden may see increased costs and poorer quality metrics if menopause-related care gaps are not addressed in care management protocols.
- Industry
External Audit Finds 97% of UnitedHealth HouseCalls Diagnoses Supported by Medical Records
An external audit of UnitedHealth's HouseCalls program found that nearly 97% of diagnoses identified during senior home visits were supported by patients' medical records. The audit was conducted amid scrutiny of home visit programs used to identify conditions for Medicare Advantage risk adjustment. UnitedHealth released the findings to validate the program's integrity following questions about diagnosis coding practices in home-based assessments. The results address ongoing concerns from regulators and policymakers about the accuracy of diagnosis reporting in value-based care arrangements.
- Industry
Safety Net CIOs Tighten IT Spending Amid Medicaid Budget Reductions
Public safety net systems like Valleywise Health in Maricopa County are applying stricter financial scrutiny to technology investments as Medicaid funding reductions take effect. Chief information officers are requiring business cases for every technology decision, intensifying pre-existing budget discipline. The approach reflects broader operational adjustments underway at safety net providers preparing for sustained Medicaid cuts. The article does not specify timing of cuts or which technology investments are being deferred or prioritized.
- Industry
UnitedHealth HouseCalls Program Reduces Hospitalizations by 5%, ER Visits by 4%
UnitedHealth Group reported that its HouseCalls in-home health program resulted in up to 5% fewer inpatient stays and 4% fewer emergency room visits for older adults with chronic conditions like diabetes and hypertension in the year following their visit. The findings come from an external analysis of initial program results announced Tuesday. The program targets Medicare Advantage and dual-eligible beneficiaries with in-home preventive visits. Results suggest potential value for managed care organizations exploring home-based interventions to reduce acute care utilization among high-risk populations.
- Industry
Trump Officials Press Drug Industry to Onshore Generic Manufacturing
Secretary of State Marco Rubio, HHS Secretary Robert F. Kennedy Jr., and CMS Administrator Chris Klomp held a private meeting with pharmaceutical industry leaders to encourage domestic production of generic drugs. The officials are pushing companies to shift manufacturing capacity from overseas facilities, particularly from China and India, back to the United States. The timing and specific policy mechanisms for incentivizing onshoring were not detailed in the reporting. The initiative reflects ongoing federal concerns about pharmaceutical supply chain vulnerabilities that have periodically disrupted access to essential medications, including those covered by Medicaid managed care plans.
- Industry
MHPA Submits Congressional Testimony on Generic Drug Shortage Legislation
Medicaid Health Plans of America (MHPA) provided testimony to Congress regarding legislative proposals to address drug shortages and ensure access to affordable generic drugs, with particular focus on sterile injectable medications. The trade association representing Medicaid managed care organizations weighed in on pending federal legislation aimed at stabilizing the generic drug supply chain. MHPA's position supports congressional efforts to resolve shortages that affect Medicaid beneficiaries' access to essential medications.
- Industry
FDA Approves Over-the-Counter CGM for Childhood Obesity Management
The FDA has approved an over-the-counter continuous glucose monitor (CGM) for use in young children, including toddlers as young as two years old, as a tool for childhood obesity management. The approval represents a significant shift in glucose monitoring technology from prescription diabetes management to preventive wellness applications in the pediatric population. Medical experts are evaluating the clinical benefits of real-time glucose data for obesity prevention against potential risks including device-related anxiety, misinterpretation of normal glucose fluctuations in non-diabetic children, and the appropriateness of medical device use in very young children. The approval takes effect immediately with retail availability expected in the coming months.